Crinetics Pharmaceuticals...

NASDAQ: CRNX · Real-Time Price · USD
30.73
1.04 (3.50%)
At close: Aug 15, 2025, 3:59 PM
30.69
-0.13%
After-hours: Aug 15, 2025, 06:45 PM EDT

Crinetics Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.04M 4.01M 4.74M 1.08M
Cost of Revenue
n/a 1.1M 1.39M 1.26M
Gross Profit
1.04M 4.01M 3.35M -184K
Operating Income
-338.85M -222.61M -167.88M -107.7M
Interest Income
41.44M 13.44M 4.32M 157K
Pretax Income
-298.41M -214.53M -163.92M -107.64M
Net Income
-298.41M -214.53M -163.92M -107.64M
Selling & General & Admin
99.74M 58.09M 42.39M 24.52M
Research & Development
240.16M 168.53M 130.22M 84.25M
Other Expenses
-2.79M n/a -1.39M -1.26M
Operating Expenses
337.11M 226.62M 171.23M 107.52M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
339.89M 226.62M 172.62M 108.78M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
80.78M 58.07M 51.98M 38.44M
Shares Outstanding (Diluted)
80.78M 58.07M 51.98M 38.44M
EPS (Basic)
-3.69 -3.69 -3.15 -2.8
EPS (Diluted)
-3.69 -3.69 -3.15 -2.8
EBITDA
-338.85M -221.51M -166.9M -106.78M
EBIT
-338.85M -222.61M -167.88M -107.7M
Depreciation & Amortization
2.79M 1.1M 1.39M 1.26M